Mel J. Yeates
Articles by Mel J. Yeates
| 4 min read
Microcombs could be used in many ways, including detecting disease and finding new planets
| 3 min read
Data on HOOKIPA’s cancer therapeutics have been published in Cell Reports Medicine
| 2 min read
The Quinten Group spins off Quinten Health, using AI for precision care and real-world data science
| 3 min read
Weill Neurohub joins forces with Genentech and Roche on neuroscience and CNS disorders
| 3 min read
Topline data from a recent Eli Lilly clinical trial indicate that tirzepatide led to superior A1C and body weight reductions from baseline compared to injectable semaglutide in adults with type 2 diabetes.
| 2 min read
EMA grants Orphan Drug designation to JR-171 for the treatment of mucopolysaccharidosis type I
| 3 min read
New biomarkers can predict risk of patients dying from bacteremia
| 4 min read
Highlights of some of the most recent new R&D tools to curb the pandemic
| 4 min read
The anti-CD117 antibody is being evaluated as a conditioning agent prior to blood stem cell transplantation
| 3 min read
Amicus’ engineered hGLA showed greater substrate reduction than wildtype hGLA
| 3 min read
Two leading scientists call on health agencies to invest in broadly effective vaccines
| 3 min read
BetterLife enters research agreement with UCSD for TD-0148A behavioral pharmacology studies
| 4 min read
High tumor mutation burden can predict immunotherapy response only in subset of cancers
| 3 min read
New collaborations will give I-Mab access to cutting edge technology platforms for developing novel drug molecules
| 3 min read
Selexis and BITT enter agreement to advance BITT’s TNFR2 antagonist antibody therapy
Page 1 of 39 - 574 Total Items
